154 related articles for article (PubMed ID: 35304995)
21. Diagnostic accuracy of different noninvasive scores for detecting advanced fibrosis in chronic hepatitis B.
Hamidi AA; Oncul A; Ozguven BY; Sevgi DY; Gunduz A; Uzun N; Dokmetas I
Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1439-1443. PubMed ID: 31033847
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the diagnostic validity of noninvasive tests for predicting liver fibrosis stage in chronic hepatitis B patients.
Çelik D; Tatar B; Köse Ş; Ödemiş İ
Acta Gastroenterol Belg; 2020; 83(3):419-425. PubMed ID: 33094589
[TBL] [Abstract][Full Text] [Related]
23. Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B.
Wu X; Cai B; Su Z; Li Y; Xu J; Deng R; Wang L
J Clin Lab Anal; 2018 May; 32(4):e22341. PubMed ID: 29251384
[TBL] [Abstract][Full Text] [Related]
24. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy.
Kim MN; Lee JH; Chon YE; Ha Y; Hwang SG
Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):433-439. PubMed ID: 31490417
[TBL] [Abstract][Full Text] [Related]
25. The gamma-glutamyl transferase to platelet ratio for noninvasive evaluation of liver fibrosis in patients with primary biliary cholangitis.
Avcioğlu U; Eruzun H; Ustaoğlu M
Medicine (Baltimore); 2022 Oct; 101(40):e30626. PubMed ID: 36221370
[TBL] [Abstract][Full Text] [Related]
26. A new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection.
Ben Ayed H; Koubaa M; Yaich S; Rekik K; Ben Jemaa T; Maaloul I; Marrekchi C; Damak J; Ben Jemaa M
Med Mal Infect; 2019 Nov; 49(8):607-615. PubMed ID: 30871816
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic thresholds and performance of noninvasive fibrosis scores are limited by age in patients with chronic hepatitis B.
Wang W; Zhao X; Li G; Wang L; Chen Y; Ma K; Chen G; Chen T; Han M; Ning Q; Zhao X
J Med Virol; 2019 Jul; 91(7):1279-1287. PubMed ID: 30788841
[TBL] [Abstract][Full Text] [Related]
28. Evaluation and comparison of the diagnostic performance of routine blood tests in predicting liver fibrosis in chronic hepatitis B infection.
Lu W; Zhang YP; Zhu HG; Zhang T; Zhang L; Gao N; Chang DY; Yin J; Zhou XY; Li MY; Li YT; Li ZZ; He Q; Geng Y
Br J Biomed Sci; 2019 Jul; 76(3):137-142. PubMed ID: 31062646
[No Abstract] [Full Text] [Related]
29. Mean Platelet Volume, Red Cell Distribution Width to Platelet Count Ratio, Globulin Platelet Index, and 16 Other Indirect Noninvasive Fibrosis Scores: How Much Do Routine Blood Tests Tell About Liver Fibrosis in Chronic Hepatitis C?
Thandassery RB; Al Kaabi S; Soofi ME; Mohiuddin SA; John AK; Al Mohannadi M; Al Ejji K; Yakoob R; Derbala MF; Wani H; Sharma M; Al Dweik N; Butt MT; Kamel YM; Sultan K; Pasic F; Singh R
J Clin Gastroenterol; 2016 Jul; 50(6):518-23. PubMed ID: 26974762
[TBL] [Abstract][Full Text] [Related]
30. Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta.
Kalkan Ç; Yılmaz Y; Erdoğan BD; Savaş B; Yurdcu E; Çalışkan A; Keskin O; Gencdal G; Zeybel M; Törüner M; Bozdayi AM; Idilman R; Yurdaydin C
J Viral Hepat; 2023 May; 30(5):406-416. PubMed ID: 36651603
[TBL] [Abstract][Full Text] [Related]
31. Utility of Serum Biomarker Indices for Staging of Hepatic Fibrosis Before and After Venesection in Patients With Hemochromatosis Caused by Variants in HFE.
Chin J; Powell LW; Ramm LE; Hartel GF; Olynyk JK; Ramm GA
Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1459-1468.e5. PubMed ID: 32745684
[TBL] [Abstract][Full Text] [Related]
32. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
Başar O; Yimaz B; Ekiz F; Giniş Z; Altinbaş A; Aktaş B; Tuna Y; Çoban S; Delibaş N; Yüksel O
Clin Res Hepatol Gastroenterol; 2013 Apr; 37(2):152-8. PubMed ID: 23391746
[TBL] [Abstract][Full Text] [Related]
33. The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection.
Lee J; Kim MY; Kang SH; Kim J; Uh Y; Yoon KJ; Kim HS
Br J Biomed Sci; 2018 Jul; 75(3):128-132. PubMed ID: 29893189
[TBL] [Abstract][Full Text] [Related]
34. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.
Wang RQ; Zhang QS; Zhao SX; Niu XM; Du JH; Du HJ; Nan YM
J Int Med Res; 2016 Dec; 44(6):1302-1313. PubMed ID: 28322102
[TBL] [Abstract][Full Text] [Related]
35. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
Sheptulina A; Shirokova E; Nekrasova T; Blum H; Ivashkin V
J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
[TBL] [Abstract][Full Text] [Related]
36. Performance of several simple, noninvasive models for assessing significant liver fibrosis in patients with chronic hepatitis B.
Zeng X; Xu C; He D; Li M; Zhang H; Wu Q; Xiang D; Wang Y
Croat Med J; 2015 Jun; 56(3):272-9. PubMed ID: 26088852
[TBL] [Abstract][Full Text] [Related]
37. Comparison of two-dimensional shear wave elastography, magnetic resonance elastography, and three serum markers for diagnosing fibrosis in patients with chronic hepatitis B: a meta-analysis.
Dong B; Lyu G; Chen Y; Lin G; Wang H; Qin R; Gu J
Expert Rev Gastroenterol Hepatol; 2021 Sep; 15(9):1077-1089. PubMed ID: 33487039
[TBL] [Abstract][Full Text] [Related]
38. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
[No Abstract] [Full Text] [Related]
39. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.
Kim WR; Berg T; Asselah T; Flisiak R; Fung S; Gordon SC; Janssen HL; Lampertico P; Lau D; Bornstein JD; Schall RE; Dinh P; Yee LJ; Martins EB; Lim SG; Loomba R; Petersen J; Buti M; Marcellin P
J Hepatol; 2016 Apr; 64(4):773-80. PubMed ID: 26626497
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and Prognostic Value of Aspartate Transaminase-to-platelet Ratio Index, Gamma-glutamyl Transpeptidase-to-platelet Ratio, and Fibrosis-4 for Compensated Hepatitis B-related Liver Cirrhosis.
Tao J; Li W; Ma X; Kong S; An Q; Wang X
J Coll Physicians Surg Pak; 2023 Aug; 33(8):941-943. PubMed ID: 37553938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
